New MultiCenter Prospective Study Demonstrates Signatera’s Clinical Utility in Merkel Cell Carcinoma
Study reports high accuracy of Signatera for surveillance of MCC patients, suggests potential to reduce frequency of surveillance imaging AUSTIN, Texas, July 26, 2024--(BUSINESS WIRE)--Natera, Inc. (...